Awarded - Drugs of ATC group L04AB02, Infliximab parent. 100 mg - 8922664

World Biggest Tenders Source

This tender with title Awarded - Drugs of ATC group L04AB02, Infliximab parent. 100 mg - 8922664 -- Contract Value: 2 667 150,00EUR has been published on Bidding Source portal dated 14 Oct 2026 for the country of Slovakia. It has been categorized on Antineoplastic and immunomodulating agents. For similar tenders you can see tenders mentioned below of this page.

Contract Value: 2 667 150,00EUR

General Information

Slovakia

Tender Title :

Awarded - Drugs of ATC group L04AB02, Infliximab parent. 100 mg - 8922664
Contract Value: 2 667 150,00EUR

Tender Type :

Contract Award

Reference No. :

8922664

Country :

Slovakia

Publish Date :

14 Oct 2026

Notice Language :

English

Tender Categories (CPVs) :

Antineoplastic and immunomodulating agents

Full Tender Details :

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

Awarded - Daratumumab - 478498 Slovakia Awarded - 422169 - Slovakia – Antineoplastic and immunomodulating agents – Drugs of ATC group L03AB07 Slovakia 378344 - Slovakia – Antineoplastic and immunomodulating agents – Antineoplastic agents for hospital pharmacy -- <b>Contract Value: 70 670,00 EUR</b> Slovakia Awarded - 85998- Slovakia – Antineoplastic and immunomodulating agents – Cetuximab -- <b>Contract Value: 98 000,00 EUR</b> Slovakia 844448-Awarded - Slovakia – Antineoplastic and immunomodulating agents – Antineoplastic and immunomodulating agents Slovakia 832353- Slovakia – Antineoplastic and immunomodulating agents – Drugs of ATC group L01FA01 Slovakia 801300-Awarded - Slovakia – Antineoplastic and immunomodulating agents – Drugs of ATC group L01FG01 Slovakia 774719- Slovakia – Antineoplastic and immunomodulating agents – Cetuximab Slovakia 767138- Slovakia – Antineoplastic and immunomodulating agents – Drugs of ATC group L01FA01 Slovakia 628158-Awarded - Slovakia – Antineoplastic and immunomodulating agents – Drugs of ATC group L01FD01 Slovakia

Awarded - Drugs of ATC group L04AB02, Infliximab parent. 100 mg - 8922664

Contract Value: 2 667 150,00EUR

General Information

Slovakia

Similar Tenders

Antineoplastic and immunomodulating agents Tenders

Slovakia Tenders

Europe Tenders

Tenders

info@biddingsource.com